Small surface, big effects, and big challenges: toward understanding enzymatic activity at the inorganic nanoparticle–substrate interface

Algar, W. R., Jeen, T., Massey, M., Peveler, W. J. and Asselin, J. (2019) Small surface, big effects, and big challenges: toward understanding enzymatic activity at the inorganic nanoparticle–substrate interface. Langmuir, 35, pp. 7067-7091. (doi: 10.1021/acs.langmuir.8b02733) (PMID:30415548)

173363.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.



Enzymes are important biomarkers for molecular diagnostics and targets for the action of drugs. In turn, inorganic nanoparticles (NPs) are of interest as materials for biological assays, biosensors, cellular and in vivo imaging probes, and vectors for drug delivery and theranostics. So how does an enzyme interact with a NP, and what are the outcomes of multivalent conjugation of its substrate to a NP? This invited feature article addresses the current state of the art in answering this question. Using gold nanoparticles (Au NPs) and semiconductor quantum dots (QDs) as illustrative materials, we discuss aspects of enzyme structure–function and the properties of NP interfaces and surface chemistry that determine enzyme–NP interactions. These aspects render the substrate-on-NP configurations far more complex and heterogeneous than the conventional turnover of discrete substrate molecules in bulk solution. Special attention is also given to the limitations of a standard kinetic analysis of the enzymatic turnover of these configurations, the need for a well-defined model of turnover, and whether a “hopping” model can account for behaviors such as the apparent acceleration of enzyme activity. A detailed and predictive understanding of how enzymes turn over multivalent NP-substrate conjugates will require a convergence of many concepts and tools from biochemistry, materials, and interface science. In turn, this understanding will help to enable rational, optimized, and value-added designs of NP bioconjugates for biomedical and clinical applications.

Item Type:Articles
Additional Information:The authors thank the Office of Naval Research (program manager: L. Kienker), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation (CFI), the British Columbia Knowledge Development Fund, and the University of British Columbia for support of their research program. W.R.A. gratefully acknowledges a Canada Research Chair (Tier 2), a Michael Smith Foundation for Health Research Scholar Award, and an Alfred P. Sloan Fellowship. T.J. gratefully acknowledges support from the NSERC CREATE NanoMat program. W.J.P. gratefully acknowledges the Izaak Walton Killam Memorial Fund for a postdoctoral research fellowship and the University of Glasgow for a Lord Kelvin Adam Smith Fellowship
Glasgow Author(s) Enlighten ID:Peveler, Dr William
Authors: Algar, W. R., Jeen, T., Massey, M., Peveler, W. J., and Asselin, J.
College/School:College of Science and Engineering > School of Engineering > Biomedical Engineering
Research Group:Peveler
Journal Name:Langmuir
Publisher:American Chemical Society
ISSN (Online):1520-5827
Published Online:11 November 2018
Copyright Holders:Copyright © 2018 American Chemical Society
First Published:First published in Langmuir 35:7067-7091
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record